Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: Final 3-Year Results of a Phase 2 Study

Takaaki Ono, Masayuki Hino, Itaru Matsumura, Shin Fujisawa, Kenichi Ishizawa, Emiko Sakaida, Naohiro Sekiguchi, Chiho Ono, Mana Aizawa, Yusuke Tanetsugu, Yuichiro Koide, Naoto Takahashi

Blood (2021) 138 (Supplement 1): 2557.

https://doi.org/10.1182/blood-2021-145164

Published: 2021

Journal Articles

Two -Year Follow-up Data of Phase II Study of Tirabrutinib, a Second-Generation Bruton's Tyrosine Kinase Inhibitor, in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström's Macroglobulinemiatwo -Year Follow-up Data of Phase II Study of Tirabrutinib, a Second-Generation Bruton's Tyrosine Kinase Inhibitor, in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström's Macroglobulinemia

Kenshi Suzuki, Naohiro Sekiguchi, Shinya Rai, Wataru Munakata, Hiroshi Handa, Hirohiko Shibayama, Tomoyuki Endo, Yasuhito Terui, Noriko Iwaki, Noriko Fukuhara, Hiro Tatetsu, Shinsuke Iida, Takayuki Ishikawa, Daisuke Iguchi, Koji Izutsu

Blood (2021) 138 (Supplement 1): 1352.

https://doi.org/10.1182/blood-2021-146744

Published: 2021

Journal Articles

Effect of Pembrolizumab Monotherapy Versus Brentuximab Vedotin (BV) on Symptoms Associated with Health-Related Quality of Life (HRQoL) in Relapsed/Refractory (R/R) Classical Hodgkin Lymphoma (cHL) in the Randomized, Phase 3, Keynote-204 Study

Pier Luigi Zinzani, MD, Radhakrishnan Ramchandren, Armando Santoro, Ewa Paszkiewicz-Kozik, Robin Gasiorowski, Nathalie A Johnson, MD PhD, José S. R. de Oliveira, Valeria Buccheri, Guilherme Fleury Perini, Michael Dickinson, DMed Sci, Andrew McDonald, Muhit Ozcan, Naohiro Sekiguchi, Monika Raut, Hilde Giezek, Akash Nahar, John Kuruvilla, MD

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-139416

Published: 2020

Journal Articles

Effect of Pembrolizumab (Pembro) Monotherapy Versus Brentuximab Vedotin (BV) on Patients (Pts) with Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL): Exploratory Analysis of the Randomized, Phase 3 Keynote-204 Study By Prior Lines of Therapy

John Kuruvilla, MD, Radhakrishnan Ramchandren, Armando Santoro, Ewa Paszkiewicz-Kozik, Robin Gasiorowski, Nathalie A Johnson, MD PhD, Laura Maria Fogliatto, Iara Goncalves, José de Oliveira, Valeria Buccheri, Guilherme Fleury Perini, Neta Goldschmidt, Irina Kryachok, Naohiro Sekiguchi, Jianxin Lin, Akash Nahar, Patricia Marinello, Pier Luigi Zinzani, MD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-142565

Published: 2020

Journal Articles

Phase 2 Study of Tirabrutinib (ONO/GS-4059), a Second-Generation Bruton's Tyrosine Kinase Inhibitor, Monotherapy in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström Macroglobulinemia

Wataru Munakata, Naohiro Sekiguchi, MD PhD, Rai Shinya, MD,PhD, Kenshi Suzuki, MD PhD, Hiroshi Handa, MD PhD, Hirohiko Shibayama, MD PhD, Tomoyuki Endo, MD PhD, Yasuhito Terui, MD PhD, Noriko Iwaki, MD PhD, Noriko Fukuhara, MD PhD, Hiro Tatetsu, MD PhD, Shinsuke Iida, MD PhD, Takayuki Ishikawa, MD PhD, Ryota Shiibashi, Koji Izutsu, MD PhD

Blood (2019) 134 (Supplement_1): 345.

https://doi.org/10.1182/blood-2019-124614

Published: 2019

Journal Articles

Retrospective Analysis of the Efficacy of Triplet Therapy, Including Lenalidomide, in Newly Diagnosed Multiple Myeloma Patients Who Obtained Responses Less Than VGPR after Rd Therapy

Naoki Takezako, MD PhD, Naoya Kaneko, MD, Airi Hamano, Ph, Kenichi Ito, MD, Naohiro Sekiguchi, MD, Satoshi Noto, MD, Takanori Teshima, MD

Blood (2019) 134 (Supplement_1): 5595.

https://doi.org/10.1182/blood-2019-131617

Published: 2019

Journal Articles

Phase 2 Study of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Naoto Takahashi, MD PhD, Itaru Matsumura, MD PhD, Shin Fujisawa, MD, Kenichi Ishizawa, MD PhD, Takaaki ONO, MD PhD, Emiko Sakaida, MD PhD, Naohiro Sekiguchi, MD PhD, Yusuke Tanetsugu, Kei Fukuhara, Masayuki Ohkura, Yuichiro Koide, Masayuki Hino, MD PhD

Blood (2019) 134 (Supplement_1): 4159.

https://doi.org/10.1182/blood-2019-121809

Published: 2019

Journal Articles

A New Prognostic Index for Waldenström Macroglobulinemia Based on a Multicenter Retrospective Study of the Japanese Society of Myeloma

Blood (2018) 132 (Supplement 1): 5320.

https://doi.org/10.1182/blood-2018-99-111649

Published: 2018

Journal Articles

The Efficacy and Safety of Weekly Bortezomib Containing VMP Followed By Bortezomib Maintenance Therapy in Unfit or Frail Multiple Myeloma Patients

Naoki Takezako, MD PhD, Michihide Tokuhira, MD PhD, Naohiro Sekiguchi, MD PhD, Yuya Kurihara, MD, Kenichi Ito, MD, Miwa Kurimoto, MD PhD, Kenshi Suzuki, MD PhD, Masahiro Kizaki, MD PhD

Blood (2016) 128 (22): 4529.

https://doi.org/10.1182/blood.V128.22.4529.4529

Published: 2016

Journal Articles

Recombinant Human Thrombomodulin in the Treatment of Acute Myeloid Leukemia Patients Complicated By Disseminated Intravascular Coagulation: Results of a Multicenter, Retrospective Epidemiologic Study in Japan

Naoki Takezako, MD PhD, Naohiro Sekiguchi, MD PhD, Satoshi Noto, MD, PhD, Yoshitaka Ogino, MD, Akiyoshi Miwa, MD PhD, Takayuki Ikezoe, MD PhD

Blood (2014) 124 (21): 2875.

https://doi.org/10.1182/blood.V124.21.2875.2875

Published: 2014

Journal Articles

Chromosomal Translocation (14;16)-Positive Multiple Myeloma Shows Negativity for CD56 Expression and Unfavorable Outcome Even in the Era of Novel Drugs

Blood (2014) 124 (21): 3349.

https://doi.org/10.1182/blood.V124.21.3349.3349

Published: 2014

Journal Articles

Clarithromycin Elevates the Plasma Concentration of Lenalidomide Via Inhibition of MDR1

Naoki Takezako, MD PhD, Masatomo Miura, PhD, Akihisa Nagata, MD PhD, Naohiro Sekiguchi, MD PhD, Takenori Niioka, PhD, Seiji Shida, MD, Takahiro Kobayashi, MD, Maiko Abumiya, Akiyoshi Miwa, MD PhD, Naoto Takahashi, MD PhD

Blood (2014) 124 (21): 3479.

https://doi.org/10.1182/blood.V124.21.3479.3479

Published: 2014

Journal Articles

Subcutaneous Injection Of Bortezomib, Combined With Doxorubicin and Dexamethasone (sPAD) Is Effective and Safety Induction Therapy For Untreated Multiple Myeloma Patients

Naoki Takezako, MD, PhD, Naohiro Sekiguchi, M.D., Ph.D., Akihisa Nagata, MD, PhD, Tsuyoshi Hagino, MD, PhD, Satoshi Noto, M.D., Ph.D., Kazuhiko Natori, M.D., Ph.D., Akiyoshi Miwa, MD, PhD

Blood (2013) 122 (21): 5391.

https://doi.org/10.1182/blood.V122.21.5391.5391

Published: 2013

Journal Articles

ST2 Utilizes Distinct Pathways to Suppress Inflammatory Cytokine Production and Modulate Rapid Differentiation of Human Monocytes Into CD83 + Dendritic Cells.

Naoki Takezako, MD, PhD, Naohiro Sekiguchi, M.D., Ph.D., Akihisa Nagata, Takeshi Hagino, Satoshi Noto, M.D., Ph.D., Akiyoshi Miwa, MD

Blood (2012) 120 (21): 2133.

https://doi.org/10.1182/blood.V120.21.2133.2133

Published: 2012

Journal Articles

Recombinant Human Thrombomodulin in the Treatment of Acute Myeloid Leukemia Patients Complicated by Disseminated Intravascular Coagulation: Retrospective Analysis of the Outcomes Between the Patients with Heparin and with Recombinant Human Thrombomodulin Therapy

Naoki Takezako, MD, PhD, Naohiro Sekiguchi, M.D., Ph.D., Akihisa Nagata, Satoshi Noto, M.D., Ph.D., Akiyoshi Miwa, M.D.

Blood (2011) 118 (21): 1247.

https://doi.org/10.1182/blood.V118.21.1247.1247

Published: 2011

Journal Articles

High Frequency of Loss of Heterozygosity Due to Uniparental Disomy or Allele Deletion of Ocular Adnexal MALT-Type Lymphoma.

Yoshitaka Asakura, Seishi Ogawa, Motohiro Kato, Go Yamamoto, Akiko Maeshima, Yoshihiro Matsuno, Shigenobu Suzuki, Akihiro Kaneko, Junko Nomoto, Kazuki Tanimoto, Naohiro Sekiguchi, Dai Maruyama, Sung-Won Kim, Takashi Watanabe, Kensei Tobinai, Yukio Kobayashi

Blood (2007) 110 (11): 2624.

https://doi.org/10.1182/blood.V110.11.2624.2624

Published: 2007

Journal Articles

Oligonucleotide Microarray Analysis of Ocular Adnexal MALT Lymphoma with Trisomy 18.

Naohiro Sekiguchi, Kazuki Tanimoto, Tsutomu Ohta, Junko Nomoto, Yukiko Yokota, Sung-Wong Kim, Takashi Watanabe, Akiko Maeshima, Yoshihiro Matsuno, Kensei Tobinai, Yukio Kobayashi

Blood (2006) 108 (11): 2423.

https://doi.org/10.1182/blood.V108.11.2423.2423

Published: 2006

Journal Articles

A Distinct Entity of Ocular Adnexal MALT Lymphoma with Trisomy 18.

Kazuki Tanimoto, MD, Naohiro Sekiguchi, M.D, Yukiko Yokota, Akihiro Kaneko, M.D, Shigenobu Suzuki, M.D, Dai Maruyama, M.D, Song-Wong Kim, M.D, Takashi Watanabe, M.D, Akiko Maeshima, M.D, Yoshihiro Matsuno, M.D, Kensei Tobinai, M.D, Yukio Kobayashi, M.D

Blood (2005) 106 (11): 983.

https://doi.org/10.1182/blood.V106.11.983.983

Published: 2005

Journal Articles

Diffuse Large B-Cell Lymphoma with Extra BCL-2 Gene Signals Detected by FISH Analysis Is Associated with “Non-Germinal Center Phenotype” Defined by Immnohistochemistry.

Shigeru Kusumoto, Yukio Kobayashi, Naohiro Sekiguchi, Kazuki Tanimoto, Yasushi Onishi, Yukiko Yokota, Takashi Watanabe, Akiko Maeshima, Takashi Ishida, Hiroshi Inagaki, Yoshihiro Matsuno, Ryuzo Ueda, Kensei Tobinai

Blood (2004) 104 (11): 2276.

https://doi.org/10.1182/blood.V104.11.2276.2276

Published: 2004

NARROW

Efficacy and Safety of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: Final 3-Year Results of a Phase 2 Study

Effect of Pembrolizumab Monotherapy Versus Brentuximab Vedotin (BV) on Symptoms Associated with Health-Related Quality of Life (HRQoL) in Relapsed/Refractory (R/R) Classical Hodgkin Lymphoma (cHL) in the Randomized, Phase 3, Keynote-204 Study

Effect of Pembrolizumab (Pembro) Monotherapy Versus Brentuximab Vedotin (BV) on Patients (Pts) with Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL): Exploratory Analysis of the Randomized, Phase 3 Keynote-204 Study By Prior Lines of Therapy

Phase 2 Study of Tirabrutinib (ONO/GS-4059), a Second-Generation Bruton's Tyrosine Kinase Inhibitor, Monotherapy in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström Macroglobulinemia

Retrospective Analysis of the Efficacy of Triplet Therapy, Including Lenalidomide, in Newly Diagnosed Multiple Myeloma Patients Who Obtained Responses Less Than VGPR after Rd Therapy

Phase 2 Study of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

A New Prognostic Index for Waldenström Macroglobulinemia Based on a Multicenter Retrospective Study of the Japanese Society of Myeloma

The Efficacy and Safety of Weekly Bortezomib Containing VMP Followed By Bortezomib Maintenance Therapy in Unfit or Frail Multiple Myeloma Patients

Recombinant Human Thrombomodulin in the Treatment of Acute Myeloid Leukemia Patients Complicated By Disseminated Intravascular Coagulation: Results of a Multicenter, Retrospective Epidemiologic Study in Japan

Chromosomal Translocation (14;16)-Positive Multiple Myeloma Shows Negativity for CD56 Expression and Unfavorable Outcome Even in the Era of Novel Drugs

Clarithromycin Elevates the Plasma Concentration of Lenalidomide Via Inhibition of MDR1

Subcutaneous Injection Of Bortezomib, Combined With Doxorubicin and Dexamethasone (sPAD) Is Effective and Safety Induction Therapy For Untreated Multiple Myeloma Patients

ST2 Utilizes Distinct Pathways to Suppress Inflammatory Cytokine Production and Modulate Rapid Differentiation of Human Monocytes Into CD83 + Dendritic Cells.

Recombinant Human Thrombomodulin in the Treatment of Acute Myeloid Leukemia Patients Complicated by Disseminated Intravascular Coagulation: Retrospective Analysis of the Outcomes Between the Patients with Heparin and with Recombinant Human Thrombomodulin Therapy

High Frequency of Loss of Heterozygosity Due to Uniparental Disomy or Allele Deletion of Ocular Adnexal MALT-Type Lymphoma.

Oligonucleotide Microarray Analysis of Ocular Adnexal MALT Lymphoma with Trisomy 18.

A Distinct Entity of Ocular Adnexal MALT Lymphoma with Trisomy 18.

Diffuse Large B-Cell Lymphoma with Extra BCL-2 Gene Signals Detected by FISH Analysis Is Associated with “Non-Germinal Center Phenotype” Defined by Immnohistochemistry.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only